1 April 2000 in Pharmacology
Nabumetone is a nonsteroidal anti-inflammatory (NSAI) drug which is known to cause less gastrointestinal damage than other NSAI drugs. This study was performed to evaluate whether nabumetone treatment might alter the vascular aberrations related to inflammation in a rat model of adjuvant-induced arthritis. Nabumetone treatment (120 or 240 mg·kg–1·day–1, orally) was initiated on the 15th day of adjuvant inoculation and continued for 14 days. Arthritic lesions, vascular contractile and relaxant responses and gastroduodenal histopathological preparations were evaluated 29 days after adjuvant inoculation. The contractile responses of aortic rings to phenylephrine and KCl were increased in grade 2 arthritic rats. In grade 3 arthritis only the phenylephrine contractility was decreased. The relaxant responses to acetylcholine and sodium nitroprusside were decreased in grades 2 and 3. In healthy rats, nabumetone did not change the vascular responses. After treatment of arthritic rats with nabumetone, both the contractile and relaxant response of the aortic rings returned to normal, and arthritic score and paw swelling were reduced. Gastroduodenal histopathology did not show erosions or ulcers in any of the groups. In conclusion, nabumetone improved the systemic signs and vascular alterations in experimental arthritis without showing any gastrointestinal side effects.
1 January 2022 in The Korean Journal of Pain
Neslihan Düzenli, Sibel Ülker, Gülgün Şengül, Buse Kayhan, and Aytül Önal. Korean J Pain 2022;35:66-77. https://doi.org/10.3344/kjp.2022.35.1.66
2 March 2011 in Life Sciences
24 December 2024 in Kırıkkale Üniversitesi Tıp Fakültesi Dergisi
Objective: In the chronic constriction injury (CCI) neuropathic pain rat model, usage of chromic catgut causes intense neuroinflammation and also undesirable conditions such as autotomy. This causes difficulties in the application and interpretation of pain behaviour tests. In this study, it was aimed to investigate the suitability of the use of surgical silk as a suture material in the CCI model, based on behavioural tests and certain biomarkers. Material and Methods: CCI model was created by loosely ligating the right sciatic nerves of rats with surgical silk. Tactile allodynia, thermal and mechanical hyperalgesia were evaluated on the 2nd, 7th, 14th, 21st and 29th postoperative days. Expressions of glial fibrillary acidic protein (GFAP), signal transducer and transcription activator 3 (STAT3) and its phosphorylated form (p-STAT3) were evaluated from the spinal cord tissue by western blotting technique. Results: Sciatic nerve-ligated rats did not lose weight but gained weight on days 14, 21, and 29 like control rats. Statistically significant decreases were found in pain thresholds in three different pain tests after the operation. The decrease in the pain threshold was accompanied by a statistically significant increase in GFAP protein expression in the spinal cord on days 2 and 14 simultaneously. No statistically significant difference was found in the expression of STAT3 or p-STAT3 protein in the spinal cord at any time. Conclusion: The absence of weight loss and autotomy expected from the classical CCI model, the reversal of the decrease in the pain threshold, the concomittant increase in GFAP protein expression in the spinal cord, and the absence of change in STAT3 and p-STAT3 expression in our study suggest that the model we created by tying 3 loose silk knots on the sciatic nerve has a milder course of neuroinflammation.
25 October 2019 in Ege Tıp Dergisi
İnflamatuar nitelikli romatizmal hastalıklarda, analjezikler özellikle de NSAİİ’ler “Hastalığı modifiye eden antiromatizmal ilaçlar (Disease-Modifying Anti-Rheumatic drugs; DMARDs)” ile birlikte sıklıkla kullanılan ilaçlardandır. Söz konusu ilaçlar arasındaki etkileşimler ile ilgili yapılmış kontrollü çalışmalar çok değildir ve daha çok metotreksat ve NSAİİ’ler arasındaki etkileşimler ile ilgilidir. Özellikle son yıllarda kullanımı artan biyolojik DMARD’ler ile analjezik ilaçlar arasındaki etkileşmelere yönelik kontrollü araştırmalara büyük ihtiyaç vardır. Derlememizde, DMARD’ler ile analjezik ilaçlar arasındaki etkileşimler bakımından akılcı ilaç kullanımından söz edilmiştir. Bu etkileşimler, proteine bağlanma, renal, gastrointestinal, hematolojik, hepatik fonksiyonlar ve enzim düzeyindeki değişimler ile ilgili alt başlıklar şeklinde sunulmuştur.